Lipocalin-2, a potential therapeutic target in advanced atherosclerosis
dc.contributor.author | Fernandez García, Carlos Ernesto | |
dc.contributor.author | Roldán Montero, Raquel | |
dc.contributor.author | Tarin, Carlos | |
dc.contributor.author | Martínez López, Diego | |
dc.contributor.author | Pastor Vargas, Carlos | |
dc.contributor.author | Blanco Colio, Luis Miguel | |
dc.contributor.author | Martín- Ventura, José Luis | |
dc.date.accessioned | 2024-10-24T11:42:03Z | |
dc.date.available | 2024-10-24T11:42:03Z | |
dc.date.issued | 2018-11 | |
dc.description.department | Depto. de Bioquímica y Biología Molecular | |
dc.description.faculty | Fac. de Ciencias Químicas | |
dc.description.fundingtype | Pagado por el autor | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Ministerio de Ciencia e Innovación (España) | |
dc.description.status | pub | |
dc.identifier.citation | Fernandez-García CE, Roldan-Montero R, Tarin C, Martinez-Lopez D, Pastor-Vargas C, Blanco-Colio LM, Martín-Ventura JL. Lipocalin-2, a potential therapeutic target in advanced atherosclerosis. Atherosclerosis. 2018 Nov;278:321-322. doi: 10.1016/j.atherosclerosis.2018.07.036. Epub 2018 Jul 27. PMID: 30170736. | |
dc.identifier.doi | 10.1016/j.atherosclerosis.2018.07.036 | |
dc.identifier.issn | 0021-9150 | |
dc.identifier.officialurl | https://doi.org/10.1016/j.atherosclerosis.2018.07.036 | |
dc.identifier.relatedurl | https://www.sciencedirect.com/science/article/pii/S0021915018312437?via%3Dihub | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/109401 | |
dc.journal.title | Atherosclerosis | |
dc.language.iso | eng | |
dc.page.final | 322 | |
dc.page.initial | 321 | |
dc.publisher | Elsevier | |
dc.relation.projectID | SAF2013/ 42525 | |
dc.relation.projectID | SAF2016-80843-R | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject.cdu | 577.1 | |
dc.subject.keyword | Lipocalin-2 | |
dc.subject.keyword | Atherosclerosis | |
dc.subject.keyword | Matrix metalloproteinases | |
dc.subject.keyword | Therapeutic targets | |
dc.subject.ucm | Sistema cardiovascular | |
dc.subject.ucm | Bioquímica (Química) | |
dc.subject.unesco | 3207.02 Arteriosclerosis | |
dc.subject.unesco | 2302 Bioquímica | |
dc.title | Lipocalin-2, a potential therapeutic target in advanced atherosclerosis | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 278 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 25af78c7-0077-4891-a14e-bcd8e51fe408 | |
relation.isAuthorOfPublication.latestForDiscovery | 25af78c7-0077-4891-a14e-bcd8e51fe408 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Lipocalin-2 deficiency or blockade protects against aorticabdominal aneurysm.pdf
- Size:
- 1.52 MB
- Format:
- Adobe Portable Document Format